{"DataElement":{"publicId":"14765182","version":"1","preferredName":"Multiplex Imaging Target Antigen Name","preferredDefinition":"An object fixed as a goal or point of examination; something to point at; a destination.:Any substance, generally a protein, that stimulates the immune system and elicits an immune response.  Recognition by the immune system elicits either a T-lymphocyte response, recognizing processed antigens, or a B-lymphocyte response, producing antibodies that bind to unprocessed antigens.:The words or language units by which a thing is known.","longName":"14765181v1.00:5406151v1.00","context":"CRDC","contextVersion":"1","DataElementConcept":{"publicId":"14765181","version":"1","preferredName":"Multiplex Imaging Target Antigen","preferredDefinition":"A proprietary technology platform that uses a known set of oligonucleotide barcodes in combination with methods for assessing single cell gene expression using barcode-conjugated primers, detecting cell surface expression of proteins via capture with barcode-conjugated antibodies, mapping of B-cell and T-cell receptor targets through tagging with barcode-conjugated antigens and targeted analysis of promoter effects on gene expression via CRISPR perturbation with barcode-conjugated guide RNAs.:An object fixed as a goal or point of examination; something to point at; a destination._Any substance, generally a protein, that stimulates the immune system and elicits an immune response.  Recognition by the immune system elicits either a T-lymphocyte response, recognizing processed antigens, or a B-lymphocyte response, producing antibodies that bind to unprocessed antigens.","longName":"14765173v1.00:7413930v1.00","context":"CRDC","contextVersion":"1","ObjectClass":{"publicId":"14765173","version":"1","preferredName":"Feature Barcoding","preferredDefinition":"A proprietary technology platform that uses a known set of oligonucleotide barcodes in combination with methods for assessing single cell gene expression using barcode-conjugated primers, detecting cell surface expression of proteins via capture with barcode-conjugated antibodies, mapping of B-cell and T-cell receptor targets through tagging with barcode-conjugated antigens and targeted analysis of promoter effects on gene expression via CRISPR perturbation with barcode-conjugated guide RNAs.","longName":"C202255","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Feature Barcoding","conceptCode":"C202255","definition":"A proprietary technology platform that uses a known set of oligonucleotide barcodes in combination with methods for assessing single cell gene expression using barcode-conjugated primers, detecting cell surface expression of proteins via capture with barcode-conjugated antibodies, mapping of B-cell and T-cell receptor targets through tagging with barcode-conjugated antigens and targeted analysis of promoter effects on gene expression via CRISPR perturbation with barcode-conjugated guide RNAs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"11C47AEA-59FC-38C8-E063-731AD00A6875","latestVersionIndicator":"Yes","beginDate":"2024-02-19","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2024-02-19","modifiedBy":"FINCHAMB","dateModified":"2024-02-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7413930","version":"1","preferredName":"Target Antigen","preferredDefinition":"An object fixed as a goal or point of examination; something to point at; a destination.:Any substance, generally a protein, that stimulates the immune system and elicits an immune response.  Recognition by the immune system elicits either a T-lymphocyte response, recognizing processed antigens, or a B-lymphocyte response, producing antibodies that bind to unprocessed antigens.","longName":"C25702:C268","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Target","conceptCode":"C25702","definition":"An object fixed as a goal or point of examination; something to point at; a destination.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Antigen","conceptCode":"C268","definition":"Any substance, generally a protein, that stimulates the immune system and elicits an immune response.  Recognition by the immune system elicits either a T-lymphocyte response, recognizing processed antigens, or a B-lymphocyte response, producing antibodies that bind to unprocessed antigens.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AED6372E-EB9A-64CC-E053-4EBD850A1320","latestVersionIndicator":"Yes","beginDate":"2020-09-08","endDate":null,"createdBy":"SETRAKIN","dateCreated":"2020-09-08","modifiedBy":"ONEDATA","dateModified":"2020-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2233241","version":"1","preferredName":"Medical Imaging","preferredDefinition":"Events, people, materials and activities uniquely defined by medical imaging.  ","longName":"MEDICAL IMAGING","context":"CIP","contextVersion":"2.31","origin":"DICOM:Digital Imaging and Communications in Medicine","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F96173D7-A9B4-3CBB-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-12","modifiedBy":"SBREXT","dateModified":"2006-09-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CDS:Cancer Data Service","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"11D1808C-FCD1-3ED9-E063-731AD00A41F0","latestVersionIndicator":"Yes","beginDate":"2024-02-20","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2024-02-20","modifiedBy":"FINCHAMB","dateModified":"2024-02-21","changeDescription":null,"administrativeNotes":"2/20/24 Created for CDS Imaging. BF","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5406151","version":"1","preferredName":"Name","preferredDefinition":"The words or language units by which a thing is known.","longName":"5406151v1.0","context":"NCI Standards","contextVersion":"1","type":"Non-enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2230266","version":"1","preferredName":"Tissue Banking","preferredDefinition":"Concepts linked to Tissue Banking and Pathology activities","longName":"TISSUE BANKING","context":"SPOREs","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F78BDEC8-6723-436F-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-05-20","modifiedBy":"REEVESD","dateModified":"2005-05-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2229718","version":"1","preferredName":"Name","preferredDefinition":"The words or language units by which a thing is known.","longName":"C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F6EF4E2B-76AE-72C1-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-16","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-05-16","modifiedBy":"ONEDATA","dateModified":"2005-05-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"BPV: Biospecimen Pre-analytical Variables (BPV) Program","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"39E4FF51-6546-DA89-E050-BB89AD4323AC","latestVersionIndicator":"Yes","beginDate":"2016-08-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2016-08-12","modifiedBy":"KNABLEJ","dateModified":"2020-10-13","changeDescription":"10/13/20 jk remove MCL Genomic CSI.  7-8-18 tt added MCL CSI. 11/19/18 jk added MCL CSI reference.  8/3/17 tt transferred to NCI Standards per confirmation by Gwen Dean, added CSI and reg status per Round 5 finalization task.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"8064110","version":"1","longName":"CDS (Cancer Data Service)","context":"CRDC","ClassificationSchemeItems":[{"publicId":"14470388","version":"1","longName":"Imaging","context":"CRDC"}]}],"AlternateNames":[{"name":"target_name","type":"CDS Alt Name","context":"CRDC"}],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"Data Element Target Antigen Name does not have Preferred Question Text.","url":null,"context":"CRDC"},{"name":"CDS Example","type":"EXAMPLE","description":"free text (“Keratin”, “CD163”, “DNA”)","url":null,"context":"CRDC"}],"origin":"CDS:Cancer Data Service","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"11D1889C-A4F7-4012-E063-731AD00AA608","latestVersionIndicator":"Yes","beginDate":"2024-02-20","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2024-02-20","modifiedBy":"FINCHAMB","dateModified":"2024-02-21","changeDescription":null,"administrativeNotes":"2/20/24 Created for CDS Imaging. BF","unresolvedIssues":null,"deletedIndicator":"No"}}